
-
1999
Company Description
Medafor develops novel hemostatic technology and absorbable hemostats called MPH(R), which accelerates the normal blood clotting process.
Medafor, Inc. is a medical device company that has developed and commercialized a patented hemostatic agent that has been shown to enhance and accelerate the normal blood clotting process. Medafor’s MPH technology is unparalleled in terms of safety, efficacy, and cost.
-
Manufacturer:
Science and Engineering -
Formed:
1999 -
Company Website:
-
Company E-mail:
-
Company Address:
2700 Freeway Boulevard,, Suite 800Minneapolis, MNUnited States -
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits